Integrated BioPharma (OTCMKTS:INBP) Stock Price Up 5.4% – Here’s Why

Integrated BioPharma, Inc. (OTCMKTS:INBPGet Free Report) shot up 5.4% on Monday . The company traded as high as $0.40 and last traded at $0.39. 65,682 shares traded hands during mid-day trading, an increase of 437% from the average session volume of 12,232 shares. The stock had previously closed at $0.37.

Integrated BioPharma Stock Up 5.4 %

The business’s 50 day simple moving average is $0.34 and its 200-day simple moving average is $0.28. The stock has a market capitalization of $11.82 million, a price-to-earnings ratio of 19.51 and a beta of 0.62.

About Integrated BioPharma

(Get Free Report)

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.

Featured Stories

Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.